Mebendazole

Table   Graphic  
individual studies
OutcomeTE95% CIn casesn exposedkPub. bias Congenital malformations All congenital malformations (majors, minors, majors and minors, or unspecified) De Silva, 1999 Diav-Citrin, 2003 Acs, 2005 Torp-Pedersen (Controls unexposed, NOS), 2016 41.50[0.68; 3.27]45,4901,528not evaluable Major congenital malformations De Silva, 1999 Diav-Citrin, 2003 Acs, 2005 Torp-Pedersen (Controls unexposed, NOS), 2016 41.50[0.68; 3.27]45,4901,528not evaluable Congenital heart defects Acs, 2005 15.10[0.42; 61.62]4,4793not evaluable Minor congenital malformations Torp-Pedersen (Controls unexposed, NOS), 2016 10.80[0.48; 1.34]13,6411,022not evaluable Digestive system anomalies 0----- Genital anomalies 0----- Hypospadias Acs, 2005 18.60[0.79; 93.86]3,0383not evaluable Limb defects 0----- Nervous system anomalies 0----- Polydactyly Acs, 2005 113.50[1.20; 151.44]1,7443not evaluable Growth parameters and prematurity Small for gestational age (weight) Torp-Pedersen (Controls unexposed, NOS), 2016 11.00[0.85; 1.17]70,2032,567not evaluable Neonatal disorders Neonatal death (< 28 days of life) Torp-Pedersen (Controls unexposed, NOS), 2016 10.80[0.30; 2.17]2,0602,567not evaluable Intrauterine deaths Late intrauterine deaths (> 22 weeks) Torp-Pedersen (Controls unexposed, NOS), 2016 10.90[0.39; 2.06]2,5552,567not evaluable Early intrauterine death (< 22 weeks) Diav-Citrin, 2003 11.25[0.65; 2.42]40192not evaluable Ectopic pregnancy 0----- Elective/induced termination of pregnancy Diav-Citrin, 2003 18.15[2.40; 27.73]25192not evaluable0.2100.01.0